Stockreport

Aprea Therapeutics to Present at the Life Sciences Investor Forum on September 19

Aprea Therapeutics, Inc.  (APRE) 
PDF DOYLESTOWN, Pa., Sept. 12, 2024 (GLOBE NEWSWIRE) -- Aprea Therapeutics, Inc. (Nasdaq: APRE) (“Aprea”, or the “Company”), a clinical-stage biopharmaceutical company foc [Read more]